Related Experiment Video
Updated: Jan 19, 2026

Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
Published on: August 15, 2020
Ageing as a risk factor for neurodegenerative disease
Yujun Hou1, Xiuli Dan1, Mansi Babbar1
1Laboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD, USA.
Aging significantly increases the risk of neurodegenerative diseases like Alzheimer's and Parkinson's. This review explores the links between aging hallmarks and these conditions, highlighting potential therapeutic targets.
Area of Science:
- Neuroscience
- Gerontology
- Pathology
Background:
- Aging is the primary risk factor for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).
- The prevalence of AD increases with age, affecting one in ten individuals over 65.
- Effective treatments for these progressive, irreversible diseases are limited, incurring significant costs.
Purpose of the Study:
- To review the pathogenesis of AD, PD, and other neurodegenerative diseases.
- To describe the association between the nine biological hallmarks of aging and neurodegeneration.
- To discuss aging mechanisms as potential therapeutic targets for neurodegenerative diseases.
Main Methods:
- Literature review of studies on aging and neurodegeneration.
- Analysis of the nine biological hallmarks of aging.
- Exploration of potential therapeutic strategies targeting aging mechanisms.
Main Results:
- Aging hallmarks including genomic instability, epigenetic alterations, mitochondrial dysfunction, and cellular senescence are linked to neurodegenerative disease pathogenesis.
- Loss of proteostasis, deregulated nutrient sensing, stem cell exhaustion, and altered intercellular communication also contribute.
- Telomere attrition is another key hallmark associated with these diseases.
Conclusions:
- Understanding the biological mechanisms of aging provides novel therapeutic targets for neurodegenerative diseases.
- Potential therapies include NAD+ precursors, mitophagy inducers, and cellular senescence inhibitors.
- Targeting aging processes offers a promising avenue for treating age-related neurodegenerative conditions.
More Related Videos
Related Concept Videos
07:04Modeling Age-Associated Neurodegenerative Diseases in Caenorhabditis elegans
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
19:50Interview: Protein Folding and Studies of Neurodegenerative Diseases
07:27Olfactory Assays for Mouse Models of Neurodegenerative Disease
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
07:21Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

